ARCHIVES

Study Finds 4-20% Of Those With HTLV-3 Develop AIDs Within 32 Months Or Less

This article is from The Cancer Letter archive.

Vol. 11 No. 31 | August 2, 1985

Download PDF Visit The Full Archive

Related Articles

FDA To Limit Radiation Doses from Medical Imaging

February 12, 2010

ACS Plans To Review Prostate Cancer Screening Guideline

March 20, 2009

Nominations Open for Bristol-Myers $25,000

September 29, 1978

Volasertib and LDAC Doubled Response in Older Patients

July 25, 2014

Group Sets Prostate Research Agenda; Strategy, Funding Demands to Follow

November 8, 1996

NCI director creates four new deputy director positions to manage the Institute.

February 20, 2004